股票 › PBLS
Parabilis医药 PBLS
美股市值排名 #2353
$28.53 +$0.65 (+2.33%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $28.53 0.00%
开盘$27.88
昨收$27.88
当日区间$27.11 – $28.87
成交量629.3K
市值$3.52B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$148,000.00
营业利润-$50.89M-39.3% YoY
净利润-$52.46M-50.7% YoY
摊薄每股收益-$2.32-314.6% YoY
自由现金流-$4.24M+86.4% YoY
经营现金流-$3.62M
营收，近4个季度
净利润，近4个季度
各季度摊薄每股收益
各季度自由现金流
盈利能力与资产负债表
营业利润率-117,335.8%
净利率-156,531.8%
净资产收益率-22.1%
资产收益率-19.7%
投入资本回报率-21.7%
流动比率17.91
负债/资产比率10.9%
现金及投资$1.12B
总负债$39.25M
净现金（净负债）$1.08B
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2024 ANNUAL |
|---|---|---|---|---|
| 其他流动资产 | $4.70M | $3.03M | $1.65M | $3.87M |
| 应付款 | $18.53M | $15.25M | $17.27M | $9.51M |
| -应付账款 | $18.53M | $15.04M | $17.27M | $9.51M |
| 一年内应计费用 | $10.29M | $13.94M | $8.33M | $6.55M |
| 短期债务及融资租赁负债 | $13.97M | $17.43M | $20.89M | $9.38M |
| -一年内到期债务 | $5.71M | $9.40M | $13.08M | $2.50M |
| -一年内到期融资租赁负债 | $8.26M | $8.03M | $7.81M | $6.88M |
| 一年内递延负债 | $10.37M | – | – | – |
| 流动负债合计 | $62.84M | $54.24M | $56.79M | $32.41M |
| 负债合计 | $127.53M | $139.95M | $97.34M | $92.81M |
| 总资产 | $1.18B | $384.17M | $80.82M | $149.25M |
| 流动资产合计 | $1.13B | $332.07M | $29.36M | $92.21M |
| 现金及现金等价物与短期投资 | $1.12B | $329.04M | $27.71M | $87.98M |
| -现金及现金等价物 | $1.09B | $329.04M | $27.71M | $47.28M |
| -短期投资 | $33.64M | – | $0.00 | $40.69M |
| 非流动资产合计 | $49.87M | $52.10M | $51.46M | $57.05M |
| 固定资产净值 | $42.73M | $44.36M | $46.08M | $52.93M |
| -固定资产原值 | $56.69M | $57.73M | $58.89M | $63.38M |
| -累计折旧 | -$13.97M | -$13.38M | -$12.81M | -$10.45M |
| 其他非流动资产 | $7.14M | $7.75M | $5.39M | $4.12M |
| 长期债务及融资租赁负债 | $33.54M | $35.71M | $37.81M | $56.82M |
| -长期融资租赁负债 | $33.54M | $35.71M | $37.81M | $44.03M |
| 一年以上递延负债 | $31.15M | – | – | – |
| 股东权益合计 | $1.05B | $244.22M | -$16.52M | $56.44M |
| 股东权益 | $1.05B | $244.22M | -$16.52M | $56.44M |
| 股本 | $12,000.00 | $814.54M | $509.97M | $440.38M |
| -普通股 | $12,000.00 | $0.00 | $0.00 | $0.00 |
| -优先股 | $0.00 | $814.54M | $509.97M | $440.38M |
| 资本公积 | $1.69B | $16.50M | $15.01M | $11.66M |
| 留存收益 | -$639.28M | -$586.82M | -$541.50M | -$395.62M |
| 其他流动负债 | $4.23M | $3.88M | $1.22M | $622,000.00 |
| 非流动负债合计 | $64.69M | $85.71M | $40.55M | $60.40M |
| 不影响留存收益的损益 | -$18,000.00 | – | $0.00 | $21,000.00 |
| 衍生产品负债 | – | $50.00M | – | – |
| -一年内应付关联方款项 | – | $211,000.00 | – | – |
| 应收款 | – | – | $0.00 | $360,000.00 |
| -一年内应收关联方款项 | – | – | $0.00 | $360,000.00 |
| 可转换优先证券 | – | – | $0.00 | $2.17M |
| 其他非流动负债 | – | – | $2.74M | $1.41M |
| -长期债务 | – | – | – | $12.79M |
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 报告营业总收入 | $148,000.00 | – | – | $0.00 | – |
| 营业总收入 | $148,000.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $51.03M | $47.45M | $152.08M | $36.52M | $40.24M |
| 销售及管理费用 | $11.66M | $9.70M | $26.50M | $6.39M | $6.34M |
| 非经营性利息净收入（支出） | $3.98M | $2.14M | $1.86M | $653,000.00 | $858,000.00 |
| -管理费用 | $11.66M | $9.70M | $26.50M | $6.39M | $6.34M |
| 研发费用 | $39.38M | $37.75M | $125.58M | $30.13M | $33.91M |
| 营业利润 | -$50.89M | -$47.45M | -$152.08M | -$36.52M | -$40.24M |
| 摊薄每股收益 | -$2.32 | -$0.56 | -$1.81 | -$0.56 | -$0.60 |
| 基本每股收益 | -$2.32 | -$0.56 | -$1.81 | -$0.56 | -$0.60 |
| 非经营性利息收入 | $4.19M | $2.43M | $3.39M | $1.05M | $1.26M |
| 非经营性利息支出 | $210,000.00 | $292,000.00 | $1.52M | $396,000.00 | $399,000.00 |
| 其他收入（支出） | -$5.56M | – | $4.33M | $1.06M | $1.06M |
| 其他非经营性收入（支出） | -$5.56M | – | $4.33M | $1.06M | $1.06M |
| 净利润 | -$52.46M | -$45.32M | -$145.89M | -$34.81M | -$38.33M |
| 持续经营利润 | -$52.46M | -$45.32M | -$145.89M | -$34.81M | -$38.33M |
| 归属母公司净利润 | -$52.46M | -$45.32M | -$145.89M | -$34.81M | -$38.33M |
| 优先股股息 | $14.49M | $25.56M | $41.04M | $10.18M | $9.78M |
| 归属普通股股东净利润 | -$66.96M | -$70.88M | -$186.93M | -$44.99M | -$48.11M |
| 税前利润 | -$52.46M | -$45.32M | -$145.89M | -$34.81M | -$38.33M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| -应收款变动 | $0.00 | $0.00 | $360,000.00 | $96,000.00 | $75,000.00 |
| 持续经营净利润 | -$52.46M | -$45.32M | -$145.89M | -$34.81M | -$38.33M |
| 自由现金流 | -$4.24M | -$49.57M | -$124.02M | -$31.11M | -$34.23M |
| 期初现金余额 | $331.89M | $30.57M | $50.14M | $89.96M | $50.14M |
| 现金净变动 | $758.02M | $301.33M | -$19.57M | -$6.71M | $39.82M |
| 期末现金余额 | $1.09B | $331.89M | $30.57M | $83.25M | $89.96M |
| 其他筹资费用净额 | -$2.54M | $49.37M | – | $0.00 | -$62,000.00 |
| 股票期权行使所得 | $584,000.00 | $187,000.00 | $34,000.00 | $9,000.00 | $0.00 |
| 优先股发行净额 | $0.00 | $305.25M | $67.43M | $0.00 | $67.49M |
| 债务发行及偿还净额 | -$3.91M | -$3.90M | -$3.08M | -$144,000.00 | -$140,000.00 |
| 持续经营筹资活动现金流净额 | $795.71M | $350.90M | $64.38M | -$135,000.00 | $67.29M |
| 筹资活动现金流 | $795.71M | $350.90M | $64.38M | -$135,000.00 | $67.29M |
| 投资购置及出售净额 | -$33.45M | $0.00 | $40.06M | $24.53M | $6.76M |
| 固定资产购置及出售净额 | -$616,000.00 | -$369,000.00 | -$306,000.00 | -$16,000.00 | -$74,000.00 |
| 其他非现金项目 | $1.75M | $1.74M | $6.63M | $1.62M | $1.61M |
| 折旧、折耗与摊销 | $593,000.00 | $606,000.00 | $2.50M | $618,000.00 | $654,000.00 |
| 经营活动现金流 | -$3.62M | -$49.20M | -$123.71M | -$31.09M | -$34.15M |
| 营运资金变动 | $37.52M | -$7.53M | $9.12M | $370,000.00 | $871,000.00 |
| -预付资产变动 | -$2.55M | -$2.81M | $1.51M | $1.20M | -$1.13M |
| 持续经营经营活动现金流净额 | -$3.62M | -$49.20M | -$123.72M | -$31.09M | -$34.15M |
| -应付账款及应计费用变动 | $337,000.00 | -$3.00M | $13.59M | $645,000.00 | $3.44M |
| -其他流动负债变动 | -$1.79M | -$1.72M | -$6.34M | -$1.57M | -$1.51M |
| 投资活动现金流净额 | -$34.06M | -$369,000.00 | $39.76M | $24.51M | $6.69M |
| 持续经营投资活动现金流净额 | -$34.06M | -$369,000.00 | $39.76M | $24.51M | $6.69M |
暂无评论——快来第一个聊聊 PBLS。
登录后参与讨论。